Literature DB >> 29191753

Melanin-Concentrating Hormone acts through hypothalamic kappa opioid system and p70S6K to stimulate acute food intake.

Amparo Romero-Picó1, Estrella Sanchez-Rebordelo2, Monica Imbernon3, David González-Touceda2, Cintia Folgueira4, Ana Senra2, Johan Fernø5, Clémence Blouet6, Roberto Cabrera7, Margriet van Gestel8, Roger A Adan8, Miguel López9, Rafael Maldonado7, Ruben Nogueiras10, Carlos Diéguez9.   

Abstract

Melanin-Concentrating Hormone (MCH) is one of the most relevant orexigenic factors specifically located in the lateral hypothalamic area (LHA), with its physiological relevance demonstrated in studies using several genetically manipulated mice models. However, the central mechanisms controlling MCH-induced hyperphagia remain largely uncharacterized. Here, we show that central injection of MCH in mice deficient for kappa opoid receptor (k-OR) failed to stimulate feeding. To determine the hypothalamic area responsible for this MCH/k-OR interaction, we performed virogenetic studies and found that downregulation of k-OR by adeno-associated viruses (shOprk1-AAV) in LHA, but not in other hypothalamic nuclei, was sufficient to block MCH-induced food intake. Next, we sought to investigate the molecular signaling pathway within the LHA that mediates acute central MCH stimulation of food intake. We found that MCH activates k-OR and that increased levels of phosphorylated extracellular signal regulated kinase (ERK) are associated with downregulation of phospho-S6 Ribosomal Protein. This effect was prevented when a pharmacological inhibitor of k-OR was co-administered with MCH. Finally, the specific activation of the direct upstream regulator of S6 (p70S6K) in the LHA attenuated MCH-stimulated food consumption. Our results reveal that lateral hypothalamic k-OR system modulates the orexigenic action of MCH via the p70S6K/S6 pathway.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Food intake; Hypothalamus; Kappa-opioid receptor; Melanin-Concentrating Hormone; Melanin-Concentrating Hormone (MCH) (PubChem CID: 24868207); Naloxone hydrochloride (PubChem CID: 5464092); Norbinaltorphimine dyhydrochloride (norBNI) (PubChem CID: 5480230)

Mesh:

Substances:

Year:  2017        PMID: 29191753     DOI: 10.1016/j.neuropharm.2017.11.040

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

Review 1.  Melanin-concentrating hormone and food intake control: Sites of action, peptide interactions, and appetition.

Authors:  Magen N Lord; Keshav Subramanian; Scott E Kanoski; Emily E Noble
Journal:  Peptides       Date:  2020-12-25       Impact factor: 3.750

Review 2.  Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis.

Authors:  Omar Al-Massadi; Carlos Dieguez; Marc Schneeberger; Miguel López; Markus Schwaninger; Vincent Prevot; Ruben Nogueiras
Journal:  Nat Rev Endocrinol       Date:  2021-10-04       Impact factor: 47.564

3.  κ-Opioid Signaling in the Lateral Hypothalamic Area Modulates Nicotine-Induced Negative Energy Balance.

Authors:  Patricia Seoane-Collazo; Amparo Romero-Picó; Eva Rial-Pensado; Laura Liñares-Pose; Ánxela Estévez-Salguero; Johan Fernø; Rubén Nogueiras; Carlos Diéguez; Miguel López
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 4.  The melanin-concentrating hormone system as a target for the treatment of sleep disorders.

Authors:  Liam E Potter; Christian R Burgess
Journal:  Front Neurosci       Date:  2022-09-13       Impact factor: 5.152

5.  Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway.

Authors:  Amparo Romero-Picó; Marta G Novelle; Omar Al-Massadi; Daniel Beiroa; Marta Tojo; Violeta Heras; Francisco Ruiz-Pino; Ana Senra; Miguel López; Clemence Blouet; Manuel Tena-Sempere; Rubén Nogueiras; Carlos Diéguez
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.